Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy

References

• Horvath I, Canotilho M, Chlumsky J, et al. Diagnosis and management of α 1 -antitrypsin deficiency in Europe: an expert survey. ERJ Open Res. 2019;5(1):00171–2018. doi:10.1183/23120541.00171-2018
   PubMedGoogle Scholar
• de Serres FJ, Blanco I. Prevalence of alpha1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis. 2012;6(5):277–295. doi:10.1177/1753465812457113
   PubMed Web of Science ®Google Scholar
• Meischl T, Schmid-Scherzer K, Vafai-Tabrizi F, et al. The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry. Respir Res. 2023;24(1):34. doi:10.1186/s12931-023-02338-0
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α 1 -antitrypsin deficiency. Eur Respir J. 2017;50(5):1700610. doi:10.1183/13993003.00610-2017
   PubMed Web of Science ®Google Scholar
• Edgar RG, Patel M, Bayliss S, Crossley D, Sapey E, Turner AM. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:1295–1308. doi:10.2147/COPD.S130440
   PubMed Web of Science ®Google Scholar
• Stockley RA, Turner AM. alpha-1-Antitrypsin deficiency: clinical variability, assessment, and treatment. Trends Mol Med. 2014;20(2):105–115. doi:10.1016/j.molmed.2013.11.006
   PubMed Web of Science ®Google Scholar
• Tanash HA, Nystedt-Duzakin M, Montero LC, Sveger T, Piitulainen E. The Swedish alpha1-Antitrypsin Screening Study: health Status and Lung and Liver Function at Age 34. Ann Am Thorac Soc. 2015;12(6):807–812. doi:10.1513/AnnalsATS.201410-452OC
   PubMed Web of Science ®Google Scholar
• Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251–255. doi:10.14236/jhi.v19i4.820
   PubMedGoogle Scholar
• Pillai AP, Turner AM, Stockley RA. Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in alpha1-antitrypsin deficiency. Chest. 2013;144(4):1152–1162. doi:10.1378/chest.13-0161
   PubMed Web of Science ®Google Scholar
• Blanco I, Bueno P, Diego I, et al. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update. Int J Chron Obstruct Pulmon Dis. 2017;12:561–569. doi:10.2147/COPD.S125389
   PubMed Web of Science ®Google Scholar
• Quinn M, Ellis P, Pye A, Turner AM. Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: current Perspectives. Ther Clin Risk Manag. 2020;16:1243–1255. doi:10.2147/TCRM.S234377
   PubMed Web of Science ®Google Scholar
• Lambe T, Adab P, Jordan RE, et al. Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care. Thorax. 2019;74(8):730–739. doi:10.1136/thoraxjnl-2018-212148
   PubMed Web of Science ®Google Scholar
• Scott L, Campbell AM, Campbell EJ. Evaluation of Strategies for Comprehensive Diagnostic Testing for Alpha1-Antitrypsin Deficiency that Include Quantitative Isoelectric Focusing and DNA Sequencing. Am Thoracic Society. 2016;1:445.
   Google Scholar
• Greulich T, Nell C, Herr C, et al. Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003-2015. Orphanet J Rare Dis. 2016;11(1):75. doi:10.1186/s13023-016-0453-8
   PubMedGoogle Scholar
• Greulich T, Rodriguez-Frias F, Belmonte I, Klemmer A, Vogelmeier CF, Miravitlles M. Real world evaluation of a novel lateral flow assay (AlphaKit(R) QuickScreen) for the detection of alpha-1-antitrypsin deficiency. Respir Res. 2018;19(1):151. doi:10.1186/s12931-018-0826-8
   PubMedGoogle Scholar
• Garcia-Palenzuela R, Timiraos Carrasco R, Gomez-Besteiro MI, Lavia G, Lago Pose M, Lara B. Detection of alpha-1 antitrypsin deficiency: a study on patients diagnosed with chronic obstructive pulmonary disease in primary health care. Semergen. 2017;43(4):289–294. doi:10.1016/j.semerg.2016.05.003
   PubMedGoogle Scholar
• de Miguel-Diez J, Jimenez-Garcia R, Lopez de Andres A, Zaragoza Arnaez F. Effectiveness of an Intervention to Improve Management of COPD using the AUDIT Methodology: results of the Neumo-Advance Study. Clin Drug Investig. 2019;39(7):653–664. doi:10.1007/s40261-019-00787-4
   PubMed Web of Science ®Google Scholar
• Nolte JL, Ataya A, Merrill H, Childs M, Brantly M. Alpha1-antitrypsin Deficiency-Increased Knowledge and Diagnostic Testing after Viewing Short Instructional Video. COPD. 2017;14(1):52–55. doi:10.1080/15412555.2016.1245280
   PubMedGoogle Scholar
• Soriano JB, Lucas SJ, Jones R, et al. Trends of testing for and diagnosis of α 1 -antitrypsin deficiency in the UK: more testing is needed. Eur Respir J. 2018;52(1):1800360. doi:10.1183/13993003.00360-2018
   PubMed Web of Science ®Google Scholar
• de Serres FJ, Blanco I, Fernandez-Bustillo E. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening. Copd. 2006;3(3):133–139. doi:10.1080/15412550600829257
   PubMedGoogle Scholar
• Rahaghi FF, Sandhaus RA, Strange C, et al. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. Copd. 2012;9(4):352–358. doi:10.3109/15412555.2012.669433
   PubMedGoogle Scholar
• Bradi AC, Audisho N, Casey DK, Chapman KR. Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD. 2015;12(Suppl 1):15–21. doi:10.3109/15412555.2015.1021908
   PubMedGoogle Scholar
• Campos MA, Alazemi S, Zhang G, et al. Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. Chest. 2009;135(3):600–608. doi:10.1378/chest.08-1129
   PubMed Web of Science ®Google Scholar
• Townsend S, Newsome P, Turner AM. Presentation and prognosis of liver disease in alpha-1 antitrypsin deficiency. Expert Rev Gastroenterol Hepatol. 2018;12(8):745–747. doi:10.1080/17474124.2018.1477589
   PubMed Web of Science ®Google Scholar